Janus Henderson Group’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$814K	Hold	25,642	–	–	﹤0.01%	1778
2025 Q4	$697K	Hold	25,642	–	–	﹤0.01%	1872
2025 Q3	$663K	Hold	25,642	–	–	﹤0.01%	1873
2025 Q2	$522K	Hold	25,642	–	–	﹤0.01%	1930
2025 Q1	$511K	Hold	25,642	–	–	﹤0.01%	1952
2024 Q4	$647K	Hold	25,642	–	–	﹤0.01%	1907
2024 Q3	$871K	Hold	25,642	–	–	﹤0.01%	1743
2024 Q2	$950K	Sell	25,642 -280	-1%	-$10.6K	﹤0.01%	1648
2024 Q1	$1.09M	Buy	25,922 +39	+0.2%	+$1.6K	﹤0.01%	1600
2023 Q4	$1.03M	Buy	25,883 +8,863	+52%	+$261K	﹤0.01%	1601
2023 Q3	$468K	Hold	17,020	–	–	﹤0.01%	1952
2023 Q2	$577K	Sell	17,020 -25	-0.1%	-$843	﹤0.01%	1899
2023 Q1	$614K	Buy	17,045 +8,961	+111%	+$387K	﹤0.01%	1901
2022 Q4	$360K	Buy	8,084 +1	+0%	+$36	﹤0.01%	1885
2022 Q3	$227K	Buy	8,083 +21	+0.3%	+$644	﹤0.01%	2347
2022 Q2	$217K	Sell	8,062 -19	-0.2%	-$552	﹤0.01%	2259
2022 Q1	$275K	Buy	8,081 +2	+0%	+$64	﹤0.01%	2276
2021 Q4	$312K	Buy	8,079 +4,072	+102%	+$177K	﹤0.01%	2179
2021 Q3	$216K	Buy	+4,007	New	+$188K	﹤0.01%	2041